Next Generation Sequencers-Global Market Status and Trend Report 2016-2026
Report Summary
Next Generation Sequencers-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Next Generation Sequencers industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Next Generation Sequencers 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Next Generation Sequencers worldwide, with company and product introduction, position in the Next Generation Sequencers market
Market status and development trend of Next Generation Sequencers by types and applications
Cost and profit status of Next Generation Sequencers, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Next Generation Sequencers market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Next Generation Sequencers industry.
The report segments the global Next Generation Sequencers market as:
Global Next Generation Sequencers Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Next Generation Sequencers Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-Molecule Real-time (SMRT) Sequencing
Other
Global Next Generation Sequencers Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Diagnostics
Drug Discovery
Biomarker Discovery
Others
Global Next Generation Sequencers Market: Manufacturers Segment Analysis (Company and Product introduction, Next Generation Sequencers Sales Volume, Revenue, Price and Gross Margin):
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pacific Biosciences of California, Inc. (US)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (UK)
Otogenetics Corporation (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Next Generation Sequencers-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Next Generation Sequencers industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Next Generation Sequencers 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Next Generation Sequencers worldwide, with company and product introduction, position in the Next Generation Sequencers market
Market status and development trend of Next Generation Sequencers by types and applications
Cost and profit status of Next Generation Sequencers, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Next Generation Sequencers market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Next Generation Sequencers industry.
The report segments the global Next Generation Sequencers market as:
Global Next Generation Sequencers Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Next Generation Sequencers Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-Molecule Real-time (SMRT) Sequencing
Other
Global Next Generation Sequencers Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Diagnostics
Drug Discovery
Biomarker Discovery
Others
Global Next Generation Sequencers Market: Manufacturers Segment Analysis (Company and Product introduction, Next Generation Sequencers Sales Volume, Revenue, Price and Gross Margin):
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pacific Biosciences of California, Inc. (US)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (UK)
Otogenetics Corporation (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEXT GENERATION SEQUENCERS
1.1 Definition of Next Generation Sequencers in This Report
1.2 Commercial Types of Next Generation Sequencers
1.2.1 Sequencing by Synthesis (SBS)
1.2.2 Ion Semiconductor Sequencing
1.2.3 Single-Molecule Real-time (SMRT) Sequencing
1.2.4 Other
1.3 Downstream Application of Next Generation Sequencers
1.3.1 Diagnostics
1.3.2 Drug Discovery
1.3.3 Biomarker Discovery
1.3.4 Others
1.4 Development History of Next Generation Sequencers
1.5 Market Status and Trend of Next Generation Sequencers 2016-2026
1.5.1 Global Next Generation Sequencers Market Status and Trend 2016-2026
1.5.2 Regional Next Generation Sequencers Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Next Generation Sequencers 2016-2021
2.2 Production Market of Next Generation Sequencers by Regions
2.2.1 Production Volume of Next Generation Sequencers by Regions
2.2.2 Production Value of Next Generation Sequencers by Regions
2.3 Demand Market of Next Generation Sequencers by Regions
2.4 Production and Demand Status of Next Generation Sequencers by Regions
2.4.1 Production and Demand Status of Next Generation Sequencers by Regions 2016-2021
2.4.2 Import and Export Status of Next Generation Sequencers by Regions 2016-2021
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Next Generation Sequencers by Types
3.2 Production Value of Next Generation Sequencers by Types
3.3 Market Forecast of Next Generation Sequencers by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Next Generation Sequencers by Downstream Industry
4.2 Market Forecast of Next Generation Sequencers by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEXT GENERATION SEQUENCERS
5.1 Global Economy Situation and Trend Overview
5.2 Next Generation Sequencers Downstream Industry Situation and Trend Overview
CHAPTER 6 NEXT GENERATION SEQUENCERS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Next Generation Sequencers by Major Manufacturers
6.2 Production Value of Next Generation Sequencers by Major Manufacturers
6.3 Basic Information of Next Generation Sequencers by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Next Generation Sequencers Major Manufacturer
6.3.2 Employees and Revenue Level of Next Generation Sequencers Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NEXT GENERATION SEQUENCERS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Illumina, Inc. (US)
7.1.1 Company profile
7.1.2 Representative Next Generation Sequencers Product
7.1.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Illumina, Inc. (US)
7.2 Thermo Fisher Scientific, Inc. (US)
7.2.1 Company profile
7.2.2 Representative Next Generation Sequencers Product
7.2.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific, Inc. (US)
7.3 Pacific Biosciences of California, Inc. (US)
7.3.1 Company profile
7.3.2 Representative Next Generation Sequencers Product
7.3.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Pacific Biosciences of California, Inc. (US)
7.4 Roche Holding AG (Switzerland)
7.4.1 Company profile
7.4.2 Representative Next Generation Sequencers Product
7.4.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Roche Holding AG (Switzerland)
7.5 QIAGEN N. V. (Germany)
7.5.1 Company profile
7.5.2 Representative Next Generation Sequencers Product
7.5.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of QIAGEN N. V. (Germany)
7.6 BGI (China)
7.6.1 Company profile
7.6.2 Representative Next Generation Sequencers Product
7.6.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of BGI (China)
7.7 Macrogen Inc. (South Korea)
7.7.1 Company profile
7.7.2 Representative Next Generation Sequencers Product
7.7.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Macrogen Inc. (South Korea)
7.8 Eurofins Scientific (Luxembourg)
7.8.1 Company profile
7.8.2 Representative Next Generation Sequencers Product
7.8.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Eurofins Scientific (Luxembourg)
7.9 Oxford Nanopore Technologies, Ltd. (UK)
7.9.1 Company profile
7.9.2 Representative Next Generation Sequencers Product
7.9.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Oxford Nanopore Technologies, Ltd. (UK)
7.10 Otogenetics Corporation (US)
7.10.1 Company profile
7.10.2 Representative Next Generation Sequencers Product
7.10.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Otogenetics Corporation (US)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEXT GENERATION SEQUENCERS
8.1 Industry Chain of Next Generation Sequencers
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEXT GENERATION SEQUENCERS
9.1 Cost Structure Analysis of Next Generation Sequencers
9.2 Raw Materials Cost Analysis of Next Generation Sequencers
9.3 Labor Cost Analysis of Next Generation Sequencers
9.4 Manufacturing Expenses Analysis of Next Generation Sequencers
CHAPTER 10 MARKETING STATUS ANALYSIS OF NEXT GENERATION SEQUENCERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Next Generation Sequencers in This Report
1.2 Commercial Types of Next Generation Sequencers
1.2.1 Sequencing by Synthesis (SBS)
1.2.2 Ion Semiconductor Sequencing
1.2.3 Single-Molecule Real-time (SMRT) Sequencing
1.2.4 Other
1.3 Downstream Application of Next Generation Sequencers
1.3.1 Diagnostics
1.3.2 Drug Discovery
1.3.3 Biomarker Discovery
1.3.4 Others
1.4 Development History of Next Generation Sequencers
1.5 Market Status and Trend of Next Generation Sequencers 2016-2026
1.5.1 Global Next Generation Sequencers Market Status and Trend 2016-2026
1.5.2 Regional Next Generation Sequencers Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Next Generation Sequencers 2016-2021
2.2 Production Market of Next Generation Sequencers by Regions
2.2.1 Production Volume of Next Generation Sequencers by Regions
2.2.2 Production Value of Next Generation Sequencers by Regions
2.3 Demand Market of Next Generation Sequencers by Regions
2.4 Production and Demand Status of Next Generation Sequencers by Regions
2.4.1 Production and Demand Status of Next Generation Sequencers by Regions 2016-2021
2.4.2 Import and Export Status of Next Generation Sequencers by Regions 2016-2021
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Next Generation Sequencers by Types
3.2 Production Value of Next Generation Sequencers by Types
3.3 Market Forecast of Next Generation Sequencers by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Next Generation Sequencers by Downstream Industry
4.2 Market Forecast of Next Generation Sequencers by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEXT GENERATION SEQUENCERS
5.1 Global Economy Situation and Trend Overview
5.2 Next Generation Sequencers Downstream Industry Situation and Trend Overview
CHAPTER 6 NEXT GENERATION SEQUENCERS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Next Generation Sequencers by Major Manufacturers
6.2 Production Value of Next Generation Sequencers by Major Manufacturers
6.3 Basic Information of Next Generation Sequencers by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Next Generation Sequencers Major Manufacturer
6.3.2 Employees and Revenue Level of Next Generation Sequencers Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NEXT GENERATION SEQUENCERS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Illumina, Inc. (US)
7.1.1 Company profile
7.1.2 Representative Next Generation Sequencers Product
7.1.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Illumina, Inc. (US)
7.2 Thermo Fisher Scientific, Inc. (US)
7.2.1 Company profile
7.2.2 Representative Next Generation Sequencers Product
7.2.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific, Inc. (US)
7.3 Pacific Biosciences of California, Inc. (US)
7.3.1 Company profile
7.3.2 Representative Next Generation Sequencers Product
7.3.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Pacific Biosciences of California, Inc. (US)
7.4 Roche Holding AG (Switzerland)
7.4.1 Company profile
7.4.2 Representative Next Generation Sequencers Product
7.4.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Roche Holding AG (Switzerland)
7.5 QIAGEN N. V. (Germany)
7.5.1 Company profile
7.5.2 Representative Next Generation Sequencers Product
7.5.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of QIAGEN N. V. (Germany)
7.6 BGI (China)
7.6.1 Company profile
7.6.2 Representative Next Generation Sequencers Product
7.6.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of BGI (China)
7.7 Macrogen Inc. (South Korea)
7.7.1 Company profile
7.7.2 Representative Next Generation Sequencers Product
7.7.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Macrogen Inc. (South Korea)
7.8 Eurofins Scientific (Luxembourg)
7.8.1 Company profile
7.8.2 Representative Next Generation Sequencers Product
7.8.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Eurofins Scientific (Luxembourg)
7.9 Oxford Nanopore Technologies, Ltd. (UK)
7.9.1 Company profile
7.9.2 Representative Next Generation Sequencers Product
7.9.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Oxford Nanopore Technologies, Ltd. (UK)
7.10 Otogenetics Corporation (US)
7.10.1 Company profile
7.10.2 Representative Next Generation Sequencers Product
7.10.3 Next Generation Sequencers Sales, Revenue, Price and Gross Margin of Otogenetics Corporation (US)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEXT GENERATION SEQUENCERS
8.1 Industry Chain of Next Generation Sequencers
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEXT GENERATION SEQUENCERS
9.1 Cost Structure Analysis of Next Generation Sequencers
9.2 Raw Materials Cost Analysis of Next Generation Sequencers
9.3 Labor Cost Analysis of Next Generation Sequencers
9.4 Manufacturing Expenses Analysis of Next Generation Sequencers
CHAPTER 10 MARKETING STATUS ANALYSIS OF NEXT GENERATION SEQUENCERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
